Cite
HARVARD Citation
Picaut, P. et al. (n.d.). Poster 155 Dysport®, AbobotulinumtoxinA, is Effective with a Favorable Safety Profile in the Treatment of Cervical Dystonia: A Phase III, Randomized, Double‐Blind, Placebo‐Controlled Study. PM&R. 6 (9), pp. S238-S239. [Online].